Cannabis Bioscience International Holdings, Inc.
CBIH OTC
SEC CIK 1411057
Follow Cannabis Bioscience International
Weekly email: filings, results, news
Revenue, last quarter
$11.2K
−25% vs same quarter last year
Net income
−$103.9K
+42.7% vs same quarter last year
EPS, diluted
$0.00
Operating cash flow
−$14.6K
+82.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $303K | −$548.8K |
| FY24 | $248.8K | −$651.3K |
| FY23 | $316.8K | −$1M |
| FY22 | - | - |
| FY11 | - | - |
| FY10 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 86.8% | −139.1% | −181.1% |
| FY24 | 81.7% | −195.4% | −261.8% |
| FY23 | 70.5% | −310.4% | −325.9% |
| FY22 | - | - | - |
| FY11 | - | - | - |
| FY10 | - | - | - |
- Cannabis Bioscience International
- Healthcare median
Show the numbers
| Year | Cannabis Bioscience International | Healthcare median |
|---|---|---|
| FY25 | −181.1% | −40.6% |
| FY24 | −261.8% | −60.7% |
| FY23 | −325.9% | −97.1% |
| FY22 | - | −128.5% |
| FY11 | - | −76.3% |
| FY10 | - | - |
News
No stories filed under Cannabis Bioscience International yet - coverage appears here as the news feed clusters it.